Trupanion, Inc. (NASDAQ:TRUP) Receives $52.25 Average PT from Brokerages

Trupanion, Inc. (NASDAQ:TRUP) has been given an average recommendation of “Hold” by the five research firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $52.25.

A number of research analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research note on Monday. Stifel Nicolaus decreased their target price on Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. Piper Sandler dropped their price objective on shares of Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a research note on Friday, December 19th. Finally, Wall Street Zen lowered Trupanion from a “buy” rating to a “hold” rating in a report on Saturday, December 6th.

Trupanion Stock Performance

Shares of TRUP stock opened at $38.17 on Friday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.31. Trupanion has a 52-week low of $31.00 and a 52-week high of $57.88. The business has a 50-day simple moving average of $38.18 and a 200-day simple moving average of $44.33. The stock has a market cap of $1.65 billion, a PE ratio of 106.03 and a beta of 1.62.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Thursday, November 6th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.76). Trupanion had a return on equity of 4.48% and a net margin of 1.10%.The firm had revenue of $366.92 million during the quarter, compared to analyst estimates of $361.58 million. During the same quarter in the previous year, the firm posted $0.03 earnings per share. The company’s quarterly revenue was up 12.0% on a year-over-year basis. On average, equities analysts expect that Trupanion will post 0.13 EPS for the current year.

Insider Activity

In other Trupanion news, CEO Margaret Tooth sold 9,803 shares of the stock in a transaction on Tuesday, November 25th. The stock was sold at an average price of $35.31, for a total transaction of $346,143.93. Following the sale, the chief executive officer owned 151,899 shares in the company, valued at approximately $5,363,553.69. This represents a 6.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 6,202 shares of Trupanion stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $35.45, for a total transaction of $219,860.90. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 41,307 shares of company stock worth $1,556,742 over the last 90 days. 5.42% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Trupanion

Institutional investors and hedge funds have recently bought and sold shares of the business. Federated Hermes Inc. bought a new position in shares of Trupanion in the third quarter valued at approximately $33,000. AlphaQuest LLC lifted its holdings in shares of Trupanion by 940.6% in the first quarter. AlphaQuest LLC now owns 1,051 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 950 shares in the last quarter. Pilgrim Partners Asia Pte Ltd acquired a new stake in Trupanion during the 3rd quarter worth about $39,000. Nisa Investment Advisors LLC boosted its holdings in shares of Trupanion by 44.1% during the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock worth $54,000 after purchasing an additional 300 shares during the period. Finally, Kelleher Financial Advisors acquired a new stake in shares of Trupanion during the 3rd quarter valued at $74,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.